Guangdong Jiaying Pharmaceutical Co Ltd Cash Flow Conversion Efficiency
Guangdong Jiaying Pharmaceutical Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Guangdong Jiaying Pharmaceutical Co Ltd (002198) has a cash flow conversion efficiency ratio of -0.065x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-45.73 Million ≈ $-6.69 Million USD) by net assets (CN¥709.01 Million ≈ $103.75 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Guangdong Jiaying Pharmaceutical Co Ltd (2004–2025)
Cash flow conversion efficiency of Guangdong Jiaying Pharmaceutical Co Ltd from 2004 to 2025. This chart illustrates how Guangdong Jiaying Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Guangdong Jiaying Pharmaceutical Co Ltd stock price for real-time trading data and today's change.
Guangdong Jiaying Pharmaceutical Co Ltd Cash Flow Conversion Ratio Explained
Guangdong Jiaying Pharmaceutical Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Guangdong Jiaying Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Guangdong Jiaying Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Also see 002198 market cap for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Hunan Copote Science Technology Co Ltd
SHG:600476
|
-0.072x |
|
Jiangsu Hongde Special Parts Co.Ltd.
SHE:301163
|
0.012x |
|
Rajratan Global Wire Limited
NSE:RAJRATAN
|
-0.077x |
|
Infinity Natural Resources, Inc.
NYSE:INR
|
-0.084x |
|
Aurora Cannabis Inc
NASDAQ:ACB
|
-0.008x |
|
PLINTAS
KLSE:5320
|
N/A |
|
Eurobio Scientific SA
PA:ALERS
|
0.030x |
|
Horizon Oil Ltd
AU:HZN
|
0.442x |
Annual Cash Flow Conversion Efficiency for Guangdong Jiaying Pharmaceutical Co Ltd (2004–2025)
The table below shows the annual cash flow conversion efficiency of Guangdong Jiaying Pharmaceutical Co Ltd from 2004 to 2025. Review 002198 free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥717.93 Million ≈ $105.06 Million |
CN¥9.00 Million ≈ $1.32 Million |
0.013x | -84.38% |
| 2024-12-31 | CN¥758.22 Million ≈ $110.95 Million |
CN¥60.85 Million ≈ $8.90 Million |
0.080x | -37.81% |
| 2023-12-31 | CN¥762.98 Million ≈ $111.65 Million |
CN¥98.45 Million ≈ $14.41 Million |
0.129x | +246.14% |
| 2022-12-31 | CN¥728.42 Million ≈ $106.59 Million |
CN¥27.15 Million ≈ $3.97 Million |
0.037x | -50.74% |
| 2021-12-31 | CN¥684.48 Million ≈ $100.16 Million |
CN¥51.80 Million ≈ $7.58 Million |
0.076x | -46.64% |
| 2020-12-31 | CN¥683.01 Million ≈ $99.95 Million |
CN¥96.87 Million ≈ $14.18 Million |
0.142x | +625.55% |
| 2019-12-31 | CN¥663.17 Million ≈ $97.04 Million |
CN¥12.96 Million ≈ $1.90 Million |
0.020x | -75.28% |
| 2018-12-31 | CN¥785.35 Million ≈ $114.92 Million |
CN¥62.10 Million ≈ $9.09 Million |
0.079x | +93.56% |
| 2017-12-31 | CN¥749.81 Million ≈ $109.72 Million |
CN¥30.63 Million ≈ $4.48 Million |
0.041x | -24.27% |
| 2016-12-31 | CN¥984.87 Million ≈ $144.12 Million |
CN¥53.13 Million ≈ $7.77 Million |
0.054x | +18.52% |
| 2015-12-31 | CN¥929.70 Million ≈ $136.04 Million |
CN¥42.31 Million ≈ $6.19 Million |
0.046x | -61.99% |
| 2014-12-31 | CN¥863.35 Million ≈ $126.33 Million |
CN¥103.36 Million ≈ $15.13 Million |
0.120x | +398.08% |
| 2013-12-31 | CN¥809.66 Million ≈ $118.48 Million |
CN¥19.46 Million ≈ $2.85 Million |
0.024x | +26.80% |
| 2012-12-31 | CN¥278.08 Million ≈ $40.69 Million |
CN¥5.27 Million ≈ $771.40K |
0.019x | +555.86% |
| 2011-12-31 | CN¥270.51 Million ≈ $39.58 Million |
CN¥781.89K ≈ $114.42K |
0.003x | -96.21% |
| 2010-12-31 | CN¥258.47 Million ≈ $37.82 Million |
CN¥19.70 Million ≈ $2.88 Million |
0.076x | -34.25% |
| 2009-12-31 | CN¥241.42 Million ≈ $35.33 Million |
CN¥27.98 Million ≈ $4.09 Million |
0.116x | +144.87% |
| 2008-12-31 | CN¥226.35 Million ≈ $33.12 Million |
CN¥10.71 Million ≈ $1.57 Million |
0.047x | -45.15% |
| 2007-12-31 | CN¥212.62 Million ≈ $31.11 Million |
CN¥18.35 Million ≈ $2.68 Million |
0.086x | -72.96% |
| 2006-12-31 | CN¥82.63 Million ≈ $12.09 Million |
CN¥26.37 Million ≈ $3.86 Million |
0.319x | +16.54% |
| 2005-12-31 | CN¥64.39 Million ≈ $9.42 Million |
CN¥17.63 Million ≈ $2.58 Million |
0.274x | +52.64% |
| 2004-12-31 | CN¥48.97 Million ≈ $7.17 Million |
CN¥8.78 Million ≈ $1.29 Million |
0.179x | -- |
About Guangdong Jiaying Pharmaceutical Co Ltd
Guangdong Jiaying Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of Chinese patent medicines in Mainland China. The company offers medicines primarily for the treatment of throat ailments, colds, orthopedics, rheumatism, gynecology, hepatobiliary diseases, tonics, and gastrointestinal disorders. It also provides Shuangliao Houfeng powder, Chongganling table… Read more